{56 (amoxicillin 500 MG Oral Capsule) / 28 (clarithromycin 500 MG Oral Tablet) / 28 (vonop... — RxCUI 2604804
RxNorm drug concept · Brand name pack
RxCUI 2604804
Brand name pack · BPCK
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2604804
Official name{56 (amoxicillin 500 MG Oral Capsule) / 28 (clarithromycin 500 MG Oral Tablet) / 28 (vonoprazan 20 MG Oral Tablet) } Pack [Voquezna 14 Day TriplePak 20;500;500]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asVoquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG Pack; Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)605 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Amoxicillin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is an antibiotic for infections caused by susceptible bacteria. These include ear, nose and throat, chest, urinary tract and skin infections. In adults it is also used with othe...
- Take it by mouth at the start of a meal, which helps limit stomach upset. Follow the schedule your prescriber gave you. Finish the full course even if you feel better, because stop...
- Diarrhea, nausea, vomiting and mild rash are the most common. Call your doctor if a rash spreads, if you have severe or bloody diarrhea, or if your child has repeated vomiting an h...
- What side effects are normal, and when should I call?
🕸️ Concept Web — How {56 (amoxicillin 500 MG Oral Capsule) / 28 (clar... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{56 (amoxicillin 500 MG Oral Capsule) / 28 (clarithromycin 500 MG Oral Tablet) / 28 (vonoprazan 20 MG Oral Tablet) } Pack [Voquezna 14 Day TriplePak 20;500;500]
RxCUI 2604804 Brand name pack · BPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Amoxicillin
723IN -
Clarithromycin
21212IN -
Vonoprazan
2604577IN
-
Amoxicillin
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Amoxicillin Oral Capsule
370578SCDF -
Clarithromycin Oral Tablet
371540SCDF -
Vonoprazan Oral Tablet
2604799SCDF -
Amoxicillin Oral Product
1152900SCDG -
Amoxicillin Pill
1152901SCDG -
Clarithromycin Oral Product
1152762SCDG -
Clarithromycin Pill
1152763SCDG -
Vonoprazan Oral Product
2604797SCDG - +4 more in this family
-
Amoxicillin Oral Capsule
-
Clinical & branded drugs 6
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Amoxicillin 500 MG Oral Capsule
308191SCD -
Clarithromycin 500 MG Oral Tablet
197517SCD -
Vonoprazan 20 MG Oral Tablet
2604800SCD -
Amoxicillin 500 MG
317616SCDC -
Clarithromycin 500 MG
315695SCDC -
Vonoprazan 20 MG
2604796SCDC
-
Amoxicillin 500 MG Oral Capsule
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 18 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Amoxicillin 500 MG Oral Capsule
SCD · 308191 -
Clarithromycin 500 MG Oral Tablet
SCD · 197517 -
Vonoprazan 20 MG Oral Tablet
SCD · 2604800 -
{56 (amoxicillin 500 MG Oral Capsule) / 28 (clarithromycin 500 MG Oral Tablet) / 28 (vonoprazan 20 MG Oral Tablet) } Pack
GPCK · 2604803 -
Amoxicillin 500 MG
SCDC · 317616 -
Clarithromycin 500 MG
SCDC · 315695 -
Vonoprazan 20 MG
SCDC · 2604796 -
Amoxicillin Oral Capsule
SCDF · 370578 -
Clarithromycin Oral Tablet
SCDF · 371540 -
Vonoprazan Oral Tablet
SCDF · 2604799
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 2604804 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 81520-0250-14 | 14 BLISTER PACK in 1 CARTON (81520-250-14) / 1 KIT in 1 BLI... | VOQUEZNA DUAL PAK | Phathom Pharmaceuticals Inc. | 2023-11-08 |
| 81520-0255-14 | 14 BLISTER PACK in 1 CARTON (81520-255-14) / 1 KIT in 1 BLI... | VOQUEZNA TRIPLE PAK | Phathom Pharmaceuticals Inc. | 2023-11-08 |
Observed labelers:
Phathom Pharmaceuticals Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.